85 related articles for article (PubMed ID: 25012012)
21. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
Ozakbas S; Ormeci B; Idiman E
J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
[TBL] [Abstract][Full Text] [Related]
22. From "wheelchair circuit" to "wheelchair assessment instrument for people with multiple sclerosis": reliability and validity analysis of a test to assess driving skills in manual wheelchair users with multiple sclerosis.
Vereecken M; Vanderstraeten G; Ilsbroukx S
Arch Phys Med Rehabil; 2012 Jun; 93(6):1052-8. PubMed ID: 22475057
[TBL] [Abstract][Full Text] [Related]
23. The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity.
Rossier P; Wade DT
Clin Rehabil; 2002 Feb; 16(1):75-95. PubMed ID: 11837529
[TBL] [Abstract][Full Text] [Related]
24. The 9-hole PEG test of upper extremity function: average values, test-retest reliability, and factors contributing to performance in people with Parkinson disease.
Earhart GM; Cavanaugh JT; Ellis T; Ford MP; Foreman KB; Dibble L
J Neurol Phys Ther; 2011 Dec; 35(4):157-63. PubMed ID: 22020457
[TBL] [Abstract][Full Text] [Related]
25. Validity and test-retest reliability of a measure of hand sensibility and manual dexterity in people with multiple sclerosis: the ReSense test.
Kalron A; Greenberg-Avrahami M; Achiron A
Disabil Rehabil; 2015; 37(10):914-20. PubMed ID: 25095901
[TBL] [Abstract][Full Text] [Related]
26. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
[TBL] [Abstract][Full Text] [Related]
27. Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Bosma LV; Kragt JJ; Brieva L; Khaleeli Z; Montalban X; Polman CH; Thompson AJ; Tintoré M; Uitdehaag BM
Mult Scler; 2010 Jul; 16(7):862-7. PubMed ID: 20488826
[TBL] [Abstract][Full Text] [Related]
28. Low-dose (7.5 mg) oral methotrexate for chronic progressive multiple sclerosis. Design of a randomized, placebo-controlled trial with sample size benefits from a composite outcome variable including preliminary data on toxicity.
Goodkin DE; Rudick RA; VanderBrug Medendorp S; Greene T; Schwetz KM; Fischer J; Daughtry MM; Ross J; Van Dyke C
Online J Curr Clin Trials; 1992 Sep; Doc No 19():[7723 words; 89 paragraphs]. PubMed ID: 1343611
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal assessment of hand function in individuals with multiple sclerosis.
Newsome SD; von Geldern G; Shou H; Baynes M; Marasigan RER; Calabresi PA; Zackowski KM
Mult Scler Relat Disord; 2019 Jul; 32():107-113. PubMed ID: 31085489
[TBL] [Abstract][Full Text] [Related]
30. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ
Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814
[TBL] [Abstract][Full Text] [Related]
31. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
32. Subjective and perceptual analysis of voice quality and relationship with neurological disfunction in multiple sclerosis patients.
Bauer V; Aleric Z; Jancic E; Knezevic B; Prpic D; Kacavenda A
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S17-20. PubMed ID: 24321149
[TBL] [Abstract][Full Text] [Related]
33. Measurement of ataxic symptoms with a graphic tablet: standard values in controls and validity in Multiple Sclerosis patients.
Erasmus LP; Sarno S; Albrecht H; Schwecht M; Pöllmann W; König N
J Neurosci Methods; 2001 Jul; 108(1):25-37. PubMed ID: 11459615
[TBL] [Abstract][Full Text] [Related]
34. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
Deloire M; Ruet A; Hamel D; Bonnet M; Brochet B
Mult Scler; 2010 May; 16(5):581-7. PubMed ID: 20194578
[TBL] [Abstract][Full Text] [Related]
35. Home-based training to improve manual dexterity in patients with multiple sclerosis: A randomized controlled trial.
Kamm CP; Mattle HP; Müri RM; Heldner MR; Blatter V; Bartlome S; Lüthy J; Imboden D; Pedrazzini G; Bohlhalter S; Hilfiker R; Vanbellingen T
Mult Scler; 2015 Oct; 21(12):1546-56. PubMed ID: 25623246
[TBL] [Abstract][Full Text] [Related]
36. Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis.
Kragt JJ; van der Linden FA; Nielsen JM; Uitdehaag BM; Polman CH
Mult Scler; 2006 Oct; 12(5):594-8. PubMed ID: 17086905
[TBL] [Abstract][Full Text] [Related]
37. The development and validation of the impact of multiple sclerosis scale and the symptoms of multiple sclerosis scale.
McMillan L; Moore KA
Arch Phys Med Rehabil; 2006 Jun; 87(6):832-41. PubMed ID: 16731220
[TBL] [Abstract][Full Text] [Related]
38. The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite.
Costelloe L; O'Rourke K; McGuigan C; Walsh C; Tubridy N; Hutchinson M
Mult Scler; 2008 Mar; 14(2):255-8. PubMed ID: 17942522
[TBL] [Abstract][Full Text] [Related]
39. The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Bosma LV; Kragt JJ; Brieva L; Khaleeli Z; Montalban X; Polman CH; Thompson AJ; Tintoré M; Uitdehaag BM
Mult Scler; 2009 Jun; 15(6):715-20. PubMed ID: 19383646
[TBL] [Abstract][Full Text] [Related]
40. Box and block test, hand grip strength and nine-hole peg test: correlations between three upper limb objective measures in multiple sclerosis.
Solaro C; Di Giovanni R; Grange E; Mueller M; Messmer Uccelli M; Bertoni R; Brichetto G; Tacchino A; Patti F; Pappalardo A; Prosperini L; Castelli L; Rosato R; Cattaneo D; Marengo D
Eur J Neurol; 2020 Dec; 27(12):2523-2530. PubMed ID: 32619066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
